Bloodstream infections in the COVID-19 era: results from an Italian multi-centre study

Zeno Pasquini1, Iacopo Barocci2, Lucia Brescini2

  • 1Università Politecnica delle Marche Facoltà di Medicina e Chirurgia, Clinica Malattie Infettive, Dipartimento di Scienze Biomediche e Sanità Pubblica, Macerata, Italy; Azienda Ospedaliera Ospedali Riuniti Marche Nord, Malattie Infettive, Pesaro, Italy.

Insights

Bloodstream infections (BSIs) are common in patients with coronavirus disease 2019 (COVID-19), occurring more frequently and with higher mortality. These infections, often caused by resistant bacteria, pose a significant risk during hospitalization.

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Critical Care Medicine

Background:

  • The impact of the COVID-19 pandemic on secondary infections like bloodstream infections (BSIs) requires thorough investigation.
  • Previous studies have explored the correlation between COVID-19 and superinfections, but a comprehensive assessment is still needed.

Purpose of the Study:

  • To evaluate the incidence and characteristics of bloodstream infections (BSIs) in patients with COVID-19.
  • To compare BSI rates and outcomes in COVID-19 patients versus non-COVID-19 patients during the pandemic.
  • To analyze the timing of BSI onset and associated mortality in hospitalized patients.

Main Methods:

  • A multi-centre study was conducted across four Italian hospitals.
  • Data from patients admitted between January 1 and June 30, 2020, were analyzed.
  • Clinical, demographic, and microbiological data were compared with data from the same period in 2019 and with non-COVID-19 patients admitted in 2020.

Main Results:

  • Patients with COVID-19 had a significantly higher incidence of BSIs (8.19 episodes/1000 patient-days) compared to non-COVID-19 patients (2.72/1000 patient-days) and the 2019 cohort (2.76/1000 patient-days).
  • BSI onset was delayed in COVID-19 patients (16 days) versus non-COVID-19 patients (5 days).
  • Thirty-day mortality was substantially higher in COVID-19 patients with BSIs (40.2%) compared to those without (23.7%).
  • Multi-drug-resistant pathogens frequently caused BSIs in COVID-19 patients, with variations between centers.

Conclusions:

  • Bloodstream infections are a significant secondary complication in COVID-19 patients.
  • Hospitalized COVID-19 patients face an elevated risk of developing BSIs.
  • BSIs in this population are associated with a high mortality rate, underscoring the need for vigilant management.
Abstract

Related Concept Videos

Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
842
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.8K
Sputum Studies II: Culture and Sensitivity01:20

Sputum Studies II: Culture and Sensitivity

Description
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
749
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.0K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
75
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
321